These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 29618499)

  • 21. Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.
    Perrier M; Désiré N; Storto A; Todesco E; Rodriguez C; Bertine M; Le Hingrat Q; Visseaux B; Calvez V; Descamps D; Marcelin AG; Charpentier C
    PLoS One; 2018; 13(6):e0198334. PubMed ID: 29856864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
    Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
    J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
    Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
    BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort.
    Jair K; McCann CD; Reed H; Castel AD; Pérez-Losada M; Wilbourn B; Greenberg AE; Jordan JA;
    PLoS One; 2019; 14(4):e0214820. PubMed ID: 30964884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.
    Pröll J; Paar C; Taylor N; Skocic M; Freystetter A; Blaimschein A; Mayr R; Niklas N; Atzmüller S; Raml E; Wechselberger C
    Curr HIV Res; 2022; 20(3):213-221. PubMed ID: 35331114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.
    Charpentier C; Montes B; Perrier M; Meftah N; Reynes J
    J Antimicrob Chemother; 2017 Oct; 72(10):2831-2836. PubMed ID: 29091218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of minority resistance mutations in the HIV-1 integrase coding region using next generation sequencing.
    Fonager J; Larsson JT; Hussing C; Neess Engsig F; Nielsen C; Fischer TK
    J Clin Virol; 2015 Dec; 73():95-100. PubMed ID: 26587787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Automatic Analysis of Ultradeep Pyrosequencing Raw Data to Determine Percentages of HIV Resistance Mutations in Patients Followed-Up in Hospital.
    Bellecave P; Recordon-Pinson P; Fleury H
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):85-92. PubMed ID: 26529549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Accuracy of Pan-Degenerate Amplification and Adaptation Assay for HIV-1 Drug Resistance Mutation Analysis in Low- and Middle-Income Countries.
    Kouamou V; Manasa J; Katzenstein D; McGregor AM; Ndhlovu CE; Makadzange T
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32522826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.
    Parkin NT; Avila-Rios S; Bibby DF; Brumme CJ; Eshleman SH; Harrigan PR; Howison M; Hunt G; Ji H; Kantor R; Ledwaba J; Lee ER; Matías-Florentino M; Mbisa JL; Noguera-Julian M; Paredes R; Rivera-Amill V; Swanstrom R; Zaccaro DJ; Zhang Y; Zhou S; Jennings C
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32605062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiDRM
    Aralaguppe SG; Ambikan AT; Ashokkumar M; Kumar MM; Hanna LE; Amogne W; Sönnerborg A; Neogi U
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31480341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load.
    Fogel JM; Bonsall D; Cummings V; Bowden R; Golubchik T; de Cesare M; Wilson EA; Gamble T; Del Rio C; Batey DS; Mayer KH; Farley JE; Hughes JP; Remien RH; Beyrer C; Fraser C; Eshleman SH
    J Antimicrob Chemother; 2020 Dec; 75(12):3510-3516. PubMed ID: 32772080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance.
    Van den Eede P; Van Wesenbeeck L; Verlinden Y; Feyaerts M; Smits V; Verheyen A; Vanhooren L; Deloof A; Villacian J; Pattery T
    Methods Mol Biol; 2013; 1030():37-55. PubMed ID: 23821259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments.
    Arias A; López P; Sánchez R; Yamamura Y; Rivera-Amill V
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis.
    Ouyang F; Yuan D; Zhai W; Liu S; Zhou Y; Yang H
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing.
    Huber M; Metzner KJ; Geissberger FD; Shah C; Leemann C; Klimkait T; Böni J; Trkola A; Zagordi O
    J Virol Methods; 2017 Feb; 240():7-13. PubMed ID: 27867045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan Youth.
    Novitsky V; Nyandiko W; Vreeman R; DeLong AK; Howison M; Manne A; Aluoch J; Chory A; Sang F; Ashimosi C; Jepkemboi E; Orido M; Hogan JW; Kantor R
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
    Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015-16.
    Mbunkah HA; Marzel A; Schmutz S; Kok YL; Zagordi O; Shilaih M; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Kouyos RD; Günthard HF; Metzner KJ
    J Antimicrob Chemother; 2018 Jul; 73(7):1917-1929. PubMed ID: 29635462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.